Reversal of haloperidol-induced orofacial dyskinesia by Murraya koenigii leaves in experimental animals

References

• Andreassen OA, Jørgensen HA. (2000). Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats. Implications for tardive dyskinesia? Prog Neurobiol, 61, 525–541.
   PubMed Web of Science ®Google Scholar
• Balijepalli S, Kenchappa RS, Boyd MR, Ravindranath V. (2001). Protein thiol oxidation by haloperidol results in inhibition of mitochondrial complex I in brain regions: Comparison with atypical antipsychotics. Neurochem Int, 38, 425–435.
   PubMed Web of Science ®Google Scholar
• Beers RF Jr, Sizer IW. (1952). A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem, 195, 133–140.
   PubMed Web of Science ®Google Scholar
• Burkhardt C, Kelly JP, Lim YH, Filley CM, Parker WD Jr. (1993). Neuroleptic medications inhibit complex I of the electron transport chain. Ann Neurol, 33, 512–517.
   PubMed Web of Science ®Google Scholar
• Cadet JL, Lohr JB, Jeste DV. (1986). Free radicals and tardive dyskinesia. Trends Neurosci, 9, 107–08.
   Web of Science ®Google Scholar
• Cadet JL, Lohr JB, Jeste DV. (1987). Tardive dyskinesia and schizophrenic burnout: The possible involvement of cytotoxic free radicals. In: Henn FA & DeLisi LE, ed. Handbook of Schizophrenia: The Neurochemistry & Pharmacology of Schizophrenia. Amsterdam: Elsevier, 425–38.
   Google Scholar
• Cordell GA. (1981). Introduction to the Alkaloids: A Biogenetic Approach.New York: Wiley Interscience.
   Google Scholar
• Casey DE. (2000). Tardive dyskinesia: Pathophysiology and animal models. J Clin Psychiatry, 61 Suppl 4, 5–9.
   PubMedGoogle Scholar
• Cohen G, Spina MB. (1988). Hydrogen production in neurons: Implications for understanding Parkinson’s disease. In: Hefti F, Weiner WJ, editors. Progress in Parkinson’s Research. New York: Plenum, 119–126.
   Google Scholar
• Cohen BM, Zubenko GS. (1985). In vivo effects of psychotropic agents on the physical properties of cell membranes in the rat brain. Psychopharmacology (Berl), 86, 365–368.
   PubMed Web of Science ®Google Scholar
• Coyle JT, Puttfarcken P. (1993). Oxidative stress, glutamate, and neurodegenerative disorders. Science, 262, 689–695.
   PubMed Web of Science ®Google Scholar
• Creese I, Burt DR, Snyder SH. (1976). Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science, 192, 481–483.
   PubMed Web of Science ®Google Scholar
• Egan MF, Apud J, Wyatt RJ. (1997). Treatment of tardive dyskinesia. Schizophr Bull, 23, 583–609.
   PubMed Web of Science ®Google Scholar
• Elkashef AM, Wyatt RJ. (1999). Tardive dyskinesia: Possible involvement of free radicals and treatment with vitamin E. Schizophr Bull, 25, 731–740.
   PubMed Web of Science ®Google Scholar
• Ellman GL. (1959). Tissue sulfhydryl groups. Arch Biochem Biophys, 82, 70–77.
   PubMed Web of Science ®Google Scholar
• Galili R, Mosberg, Gil-Ad I, Weizman A, Melamed E, Offen D. (2000). Haloperidol-induced neurotoxicity–possible implications for tardive dyskinesia. J Neural Transm, 107, 479–490.
   PubMed Web of Science ®Google Scholar
• Gorrod JW, Fang J. (1993). On the metabolism of haloperidol. Xenobiotica, 23, 495–508.
   PubMed Web of Science ®Google Scholar
• Gupta S, Mosnik D, Black DW, Berry S, Masand PS. (1999). Tardive dyskinesia: Review of treatments past, present, and future. Ann Clin Psychiatry, 11, 257–266.
   PubMedGoogle Scholar
• Kulkarni SK, Naidu PS. (2001). Tardive dyskinesia: An update. Drugs Today, 37, 97–119.
   PubMed Web of Science ®Google Scholar
• Fell MJ, Neill JC, Marshall KM. (2004). Effects of the classical antipsychotic haloperidol and atypical antipsychotic risperidone on weight gain, the oestrous cycle and uterine weight in female rats. Eur Neuropsychopharmacol, 14, 385–392.
   PubMedGoogle Scholar
• Misra HP, Fridovich I. (1972). The generation of superoxide radical during the autoxidation of hemoglobin. J Biol Chem, 247, 6960–6962.
   PubMed Web of Science ®Google Scholar
• Niehaus WG, Samuelson B. (1968). Formation of malon-dialdehyde from phospholipid arachidonate during microsomal lipid peroxidation. Eur J Pharmacol, 6, 126–130.
   Web of Science ®Google Scholar
• Nielsen EB, Lyon M. (1978). Evidence for cell loss in corpus striatum after long-term treatment with a neuroleptic drug (flupenithixol) in rats. Psychopharmacology (Berl), 59, 85–89.
   PubMedGoogle Scholar
• Rao LJM, Ramalakshmi K. (2007). Antioxidant and radical scavenging carbazole alkaloids from the oleoresin of curry leaves (Murraya koenigii Spreng). Food Chem, 100, 742–747.
   Web of Science ®Google Scholar
• Ravindranath V, Reed DJ. (1990). Glutathione depletion and formation of glutathione-protein mixed disulfide following exposure of brain mitochondria to oxidative stress. Biochem Biophys Res Commun, 169, 1075–1079.
   PubMedGoogle Scholar
• Richardson MA, Haugland G, Pass R, Craig TJ. (1986). The prevalence of tardive dyskinesia in a mentally retarded population. Psychopharmacol Bull, 22, 243–249.
   PubMed Web of Science ®Google Scholar
• Sathaye S, Bagul Y, Gupta S, Kaur H, Redkar R. (2011). Hepatoprotective effects of aqueous leaf extract and crude isolates of Murraya koenigii against in vitro ethanol-induced hepatotoxicity model. Exp Toxicol Pathol, 63, 587–591.
   PubMed Web of Science ®Google Scholar
• Sagara Y. (1998). Induction of reactive oxygen species in neurons by haloperidol. J Neurochem, 71, 1002–1012.
   PubMed Web of Science ®Google Scholar
• Saggu H, Cooksey J, Dexter D, Wells FR, Lees A, Jenner P, Marsden CD. (1989). A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra. J Neurochem, 53, 692–697.
   PubMed Web of Science ®Google Scholar
• Salamone JD, Lalies MD, Channell SL, Iversen SD. (1986). Behavioural and pharmacological characterization of the mouth movements induced by muscarinic agonists in the rat. Psychopharmacology (Berl), 88, 467–471.
   PubMedGoogle Scholar
• Shivakumar BR, Ravindranath V. (1993). Oxidative stress and thiol modification induced by chronic administration of haloperidol. J Pharmacol Exp Ther, 265, 1137–1141.
   PubMedGoogle Scholar
• Soares KV, Mcgrath JJ. (2002). Vitamin E for neuroleptic-induced tardive dyskinesia. Cochrane Database Syst Rev, 2.
   Google Scholar
• Vairetti M, Feletti F, Battaglia A, Pamparana F, Canonico PL, Richelmi P, Bertè F. (1999). Haloperidol-induced changes in glutathione and energy metabolism: Effect of nicergoline. Eur J Pharmacol, 367, 67–72.
   PubMedGoogle Scholar
• Vogel HG, Vogel WH. (2002). Drug Discovery & Evaluation. 2nd edition, New York, NY: Springer, 643.
   Google Scholar
• Wright AM, Bempong J, Kirby ML, Barlow RL, Bloomquist JR. (1998). Effects of haloperidol metabolites on neurotransmitter uptake and release: Possible role in neurotoxicity and tardive dyskinesia. Brain Res, 788, 215–222.
   PubMed Web of Science ®Google Scholar
• Yankuzo H, Ahmed QU, Santosa RI, Akter SF, Talib NA. (2011). Beneficial effect of the leaves of Murraya koenigii (Linn.) Spreng (Rutaceae) on diabetes-induced renal damage in vivo. J Ethnopharmacol, 135, 88–94.
   PubMedGoogle Scholar
• Zheng W, Wang SY. (2001). Antioxidant activity and phenolic compounds in selected herbs. J Agric Food Chem, 49, 5165–5170.
   PubMed Web of Science ®Google Scholar